Donald Trump’s proposed 200% tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
President Donald Trump has consistently demonstrated a preference for maintaining control over escalation rather than allowing events to dictate American strategy.
[T]he international community is waiting with bated breath to see what next the [U.S.] authorities will do to inadvertently expose FIFA's blatant hypocrisy.